Ghazal Fogeby

Ghazal Fogeby currently serves as a Board Member at Nerliens Meszansky AS since July 2024 and as CEO of Nordic Biolabs AB since March 2021, previously holding the position of Sales Director at Nordic Biolabs AB. Fogeby's extensive experience spans various leadership roles in sales and marketing within the healthcare and diagnostics sectors, including significant positions at Miele Professional, VWR, Life Genomics AB, Thermo Fisher Scientific, and Roche Diagnostics Scandinavia AB. An educational background featuring degrees in Executive MBA, Biomedicine, Pharmaceutical Science, and Chemical Engineering from the University of Gothenburg and the University of Borås supports Fogeby's expertise in achieving commercial success and driving growth across various markets.